Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
In light of the current situation, the DZNE was founded in 2009 as a member of the Helmholtz Association and the first member of the German Centers for Health Research (German Coeliac Society, DZG). Today, it consists of ten sites – Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen, Ulm and Witten – and consequently pools expertise distributed nationwide within a single research institute. More than 1,100 experts are working to understand what causes diseases of the brain and nervous system and to find new approaches for effective prevention, therapy, and patient care. Worldwide, the DZNE is one of the largest research institutes dealing with this topic.
We are driven by the desire to prevent neurodegenerative diseases and to significantly improve the quality of life of those affected. The DZNE therefore dedicates it efforts towards all aspects of neurodegenerative diseases – from biological mechanisms to personal care and patient care. In order to cover this wide range of issues, we pursue an interdisciplinary scientific strategy that includes several interlinked research areas. The scientists at the DZNE work together across the various disciplines and sites, so that new findings can be applied rapidly. Such efforts to build a bridge between science and practical application are called “translation,” and in doing this, DZNE cooperates with universities, university hospitals, research institutes and innovative companies – both in Germany and worldwide.
